1/20/2010

An international team of researchers, headed by H. Lundbeck A/S and King's College London, has formed the Novel Methods leading to New Medications in Depression and Schizophrenia, an academic-industry research tie-up that will focus on finding new ways to develop treatments for schizophrenia and depression. The project aims to develop new animal models for brain studies, as well as hardware and analysis methods that can be used in brain imaging, including MRI and PET.

Full Story:
EurekAlert!

Related Summaries